Improvements in clinical assessment and management of Difficult-to-treat Asthma in Adults

  • Heaney, Liam (Participant)
  • Michael Stevenson (Participant)
  • Diarmuid McNicholl (Participant)
  • McGarvey, Lorcan (Participant)
  • Joan Sweeney (Participant)
  • Christopher Patterson (Participant)

Impact: Health Impact, Quality of Life Impact


Heaney’s research at Queen’s University Belfast on difficult-to-treat asthma (or simply “difficult asthma”- DA) patients has led to changes in clinical management guidelines and a drive to co-ordinate and commission specialist services nationally for DA patients. It has also led to the establishment of a UK Multi-centre National Clinical Network and Patient Registry (Centres listed in Section 5). DA patients have persistent symptoms and frequent exacerbations despite being on
high dose asthma therapy. DA patients (10% of the asthmatic population) have significant morbidity and carry a high risk of asthma death. Their clinical assessment has been optimised to ensure proper management of both their asthma and non-asthma related conditions.
Impact statusOngoing
Category of impactHealth Impact, Quality of Life Impact